Search research articles
Contact Us
Filters
Showing results (101-110 of 278) with videos related to
Page
of 28
Sort By:
Kidney International Reports
|
January 1, 2019
Pink Urine Syndrome: A Combination of Insulin Resistance and Propofol
Bryan M Tucker, Mark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN
|
April 3, 2009
How can urine microscopy influence the differential diagnosis of AKI?
Mark A Perazella, Chirag R Parikh
Disease Management : DM
|
November 23, 2006
Transition of patients from chronic kidney disease to end-stage renal disease: better practices for better outcomes
Chester A Amedia, Mark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN
|
September 21, 2013
Urinary eosinophils in AIN: farewell to an old biomarker?
Mark A Perazella, Andrew S Bomback
Clinical Journal of the American Society of Nephrology : CJASN
|
November 7, 2018
Treatment of Drug-Induced Acute Tubulointerstitial Nephritis: The Search for Better Evidence
Dennis G Moledina, Mark A Perazella
Advances in Kidney Disease and Health
|
September 14, 2025
The Tubulointerstitium in Health and Disease: More Than What Meets the Eye
Mark A Perazella, Pranav S Garimella
Nature Reviews. Nephrology
|
June 3, 2010
Drug-induced acute interstitial nephritis
Mark A Perazella, Glen S Markowitz
The New England Journal of Medicine
|
March 23, 2018
Adverse Events Associated with Immune Checkpoint Blockade
Kenar D Jhaveri, Mark A Perazella
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 20, 2004
Acute interstitial nephritis associated with atazanavir, a new protease inhibitor
Ursula C Brewster, Mark A Perazella
Frontiers in Medicine
|
August 29, 2022
The role of kidney biopsy in immune checkpoint inhibitor nephrotoxicity
Emily M Moss, Mark A Perazella
Page
of 28
Search research articles
Search
Showing results (101-110 of 278) with videos related to
Sort By:
Page
of 28
Kidney International Reports
|
January 1, 2019
Pink Urine Syndrome: A Combination of Insulin Resistance and Propofol
Bryan M Tucker, Mark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN
|
April 3, 2009
How can urine microscopy influence the differential diagnosis of AKI?
Mark A Perazella, Chirag R Parikh
Disease Management : DM
|
November 23, 2006
Transition of patients from chronic kidney disease to end-stage renal disease: better practices for better outcomes
Chester A Amedia, Mark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN
|
September 21, 2013
Urinary eosinophils in AIN: farewell to an old biomarker?
Mark A Perazella, Andrew S Bomback
Clinical Journal of the American Society of Nephrology : CJASN
|
November 7, 2018
Treatment of Drug-Induced Acute Tubulointerstitial Nephritis: The Search for Better Evidence
Dennis G Moledina, Mark A Perazella
Advances in Kidney Disease and Health
|
September 14, 2025
The Tubulointerstitium in Health and Disease: More Than What Meets the Eye
Mark A Perazella, Pranav S Garimella
Nature Reviews. Nephrology
|
June 3, 2010
Drug-induced acute interstitial nephritis
Mark A Perazella, Glen S Markowitz
The New England Journal of Medicine
|
March 23, 2018
Adverse Events Associated with Immune Checkpoint Blockade
Kenar D Jhaveri, Mark A Perazella
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 20, 2004
Acute interstitial nephritis associated with atazanavir, a new protease inhibitor
Ursula C Brewster, Mark A Perazella
Frontiers in Medicine
|
August 29, 2022
The role of kidney biopsy in immune checkpoint inhibitor nephrotoxicity
Emily M Moss, Mark A Perazella
Page
of 28